Taka
US Dollar
Product Description
Functioning as a triple agonist, retatrutide activates the GLP-1, GIP, and glucagon receptors, which collectively enhance satiety, increase energy expenditure, and improve insulin sensitivity, leading to significant weight loss and improved glycemic control in clinical trials.
By mimicking the effects of these naturally occurring hormones, retatrutide helps regulate appetite and metabolism, offering a more effective approach to managing obesity compared to single-receptor therapies.
